Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fighting Cancer Resistance: Multidisciplinary Integrated Platform for a Technological Innvovative Approach to Oncotherapies

NCT05818020 is registered in ClinicalTrials.gov with National Cancer Institute, Naples as lead sponsor.

NCT NCT05818020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05818020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fighting Cancer Resistance: Multidisciplinary Integrated Platform for a Technological Innvovative Approach to Oncotherapies
Lead sponsor
National Cancer Institute, Naples
Phase
Observational
Overall status
Completed
Start date
March 2, 2020
Completion date
June 30, 2022
Enrollment
269 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

biologic